Prevalence, healthcare costs and management of non-communicable diseases in people living with human immunodeficiency virus: A scoping review

African Journal of Primary Health Care & Family Medicine

 
 
Field Value
 
Title Prevalence, healthcare costs and management of non-communicable diseases in people living with human immunodeficiency virus: A scoping review
 
Creator Gonah, Laston Moodley, Indres Hlongwana, Khumbulani
 
Subject — HIV/AIDS; co-morbidity; multi-morbidity; non-communicable diseases; hypertension; diabetes mellitus; prevalence; healthcare costs
Description Background: Coexistence of human immunodeficiency virus (HIV) and non-communicable diseases (NCDs) is an important public health issue of increasing concern. However, the prevalence, healthcare costs and management protocols for NCDs in people living with HIV (PLHIV) remain unclear in most settings.Aim: To scope evidence on prevalence, healthcare costs and disease management protocols associated with NCDs in PLHIV from studies published before July 2019.Methods: Electronic databases were searched for published articles, and reference lists were checked for relevant studies. Key terms included were HIV/AIDS, co-morbidity or multi-morbidity, NCDs, healthcare costs, treatment protocols, diabetes mellitus, hypertension in various combinations.Results: A total of 152 records were assessed, and thereafter 25 studies were included in the final review after all the elimination. Twelve of the 25 studies mostly reported prevalence of NCDs in PLHIV, 4 reported impact of HIV–NCD co-morbidity on healthcare costs and 1 reported management protocols and capacity of antiretroviral therapy (ART) sites to manage HIV–NCD co-morbidity.Conclusions: Results showed higher prevalence rates of diabetes mellitus and hypertension in PLHIV compared with HIV-negative people. However, there was inconsistency in NCD prevalence data from studies conducted in sub-Saharan African (SSA) countries, and limited research evidence on capacity of ART sites to manage NCDs in PLHIV. Low prevalence rates of NCDs reported in SSA countries could be an indication of limited capacity to screen for NCDs because of the influence of health system and/or patient-level factors. Most studies were generally limited to cross-sectional studies, with very few interventional, longitudinal studies.
 
Publisher AOSIS
 
Contributor none
Date 2020-10-19
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — Scoping Review
Format text/html application/epub+zip text/xml application/pdf
Identifier 10.4102/phcfm.v12i1.2474
 
Source African Journal of Primary Health Care & Family Medicine; Vol 12, No 1 (2020); 8 pages 2071-2936 2071-2928
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://phcfm.org/index.php/phcfm/article/view/2474/4306 https://phcfm.org/index.php/phcfm/article/view/2474/4305 https://phcfm.org/index.php/phcfm/article/view/2474/4307 https://phcfm.org/index.php/phcfm/article/view/2474/4304
 
Coverage — — —
Rights Copyright (c) 2020 Laston Gonah, Indres Moodley, Khumbulani Hlongwana https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT